The compound is called cannabizetol (CBGD), and it’s only the fourth dimeric cannabinoid ever identified in cannabis. When researchers tested it against 84 different inflammatory genes, it showed significantly higher anti-inflammatory activity than any previously studied dimeric cannabinoid. It works through the NF-κB pathway—essentially a master switch for inflammation throughout the human body—and exhibits powerful antioxidant properties that could have applications in dermatology, chronic inflammation, and potentially dozens of other medical conditions we haven’t even imagined yet.
A first-person review of the hemp-derived THC cocktail base I poured at our Cannabis Cup…
Every paper mill in the world still runs on the continuous-web design a Frenchman patented…
A new AI-assisted sci-fi satire from filmmaker Dan Levy Dagerman and the Space Weed Universe…
Spain has increased penalties for electricity theft linked to indoor cannabis cultivation after Endesa reported…
How a 52-year-old first-time grower turned trial and error into a show-stopping harvest The first…
This is the legacy knowledge drain, and it is the quiet catastrophe nobody in the…